atrial fibrillation, congestive heart failure, crtContemporary cardiac resynchronization therapy (CRT) devices are equipped with reliable and extensive diagnostic and memory features yielding full disclosure of the frequency, duration, and overall burden of atrial tachyarrhythmias.These advanced diagnostic features have demonstrated the high frequency of symptomatic and asymptomatic atrial arrhythmias, mostly atrial fibrillation (AF) in CRT patients. The loss of atrial transport function and associated tachycardia frequently result in deterioration of cardiac function and clinical deterioration. AF compromises CRT delivery due to RR interval variability and competing tachycardia, and may even result in excessive rapid ventricular pacing during atrial tracking. Atrial arrhythmias represent an important cause of poor long-term CRT benefit and prognosis unless aggressive efforts are made to slow the ventricular rate (VR). Over the last 3-5 years many important reports have addressed the diagnosis and treatment of atrial tachyarrhythmias in CRT patients. These new developments and their clinical implications form the basis of this review. Because the overwhelming majority of arrhythmias consist of AF, we shall refer, as do many workers, to atrial tachyarrhythmias simply as AF. [1][2][3][4] Although approximately 25% of patients undergoing CRT have permanent AF, 5,6 virtually all the randomized CRT trials have excluded patients with preexisting permanent AF. Evidence from relatively small studies have suggested that the CRT benefit in AF is comparable (or somewhat attenuated) to that seen in sinus rhythm provided the VR is controlled with digoxin and β-blockers. 7-11 A recent meta-analysis of 23 observational studies in a total of 7,495 patients (25.5% in AF) followed for 33 months showed that AF was associated with a higher risk of nonresponders (P = 0.001) and all-cause mortality (P = 0.015). 12 Ablation of the atrioventricular Address for reprints: S.